Loading...
XNAS
AIRS
Market cap305mUSD
Jul 10, Last price  
4.33USD
1D
3.59%
1Q
64.02%
IPO
-70.14%
Name

Airsculpt Technologies Inc

Chart & Performance

D1W1MN
XNAS:AIRS chart
P/E
P/S
2.01
EPS
Div Yield, %
Shrs. gr., 5y
1.67%
Rev. gr., 5y
19.32%
Revenues
152m
-15.82%
41,236,00062,766,000133,315,000168,794,000195,917,000180,350,000151,818,000
Net income
-12m
L+41.40%
-2,212,0007,577,00010,551,000-14,679,000-4,479,000-8,251,000-11,667,000
CFO
3m
-72.72%
4,938,00013,957,00026,633,00024,447,00023,956,00011,350,0003,096,000
Dividend
Aug 25, 20220.41 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
IPO date
Oct 29, 2021
Employees
291
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT